speb/financial-data huggingface dataset:
TMHC cash_flow (annual, 2025-12-31) — Investing Cash Flow: -154772000.00
TMHC cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -70866000.00
TMHC balance_sheet (annual, 2025-12-31) — Investments And Advances: 486978000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 486978000.00
TMHC cash_flow (annual, 2025-12-31) — Issuance Of Debt: 4430515000.00
TMHC cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 1445083000.00
TMHC balance_sheet (annual, 2025-12-31) — Line Of Credit: 0.00
TMHC balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 0.00
TMHC balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 71525000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 71525000.00
TMHC balance_sheet (annual, 2025-12-31) — Long Term Debt: 2291107000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 2291107000.00
TMHC balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2362632000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2362632000.00
TMHC cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 4190515000.00
TMHC cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 1205083000.00
TMHC cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -4088435000.00
TMHC cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -1216577000.00
TMHC balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 486978000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 486978000.00
TMHC balance_sheet (annual, 2025-12-31) — Long Term Provisions: 227641000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 227641000.00
TMHC balance_sheet (annual, 2025-12-31) — Minority Interest: 15967000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Minority Interest: 15967000.00
TMHC income_statement (annual, 2025-12-31) — Minority Interests: -8763000.00
TMHC income_statement (quarterly, 2025-12-31) — Minority Interests: -3080000.00
TMHC cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -85578000.00
TMHC cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -12132000.00
TMHC cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -381016000.00
TMHC cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -71370000.00
TMHC balance_sheet (annual, 2025-12-31) — Net Debt: 1441070000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Net Debt: 1441070000.00
TMHC income_statement (annual, 2025-12-31) — Net Income: 782500000.00
TMHC income_statement (quarterly, 2025-12-31) — Net Income: 174016000.00
TMHC income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 782500000.00
TMHC income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 174016000.00
TMHC income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 791263000.00
TMHC income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 177096000.00
TMHC income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 782500000.00
TMHC income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 174016000.00
TMHC income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 782500000.00
TMHC income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 174016000.00
TMHC cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 791263000.00
TMHC cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 177096000.00
TMHC income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 791263000.00
TMHC income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 177096000.00
TMHC income_statement (annual, 2025-12-31) — Net Interest Income: -47003000.00
TMHC income_statement (quarterly, 2025-12-31) — Net Interest Income: -11911000.00
TMHC cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -59223000.00
TMHC cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 102080000.00
TMHC cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -11494000.00
TMHC cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 102080000.00
TMHC cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -11494000.00
TMHC income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -47003000.00
TMHC income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -11911000.00
TMHC cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -19079000.00
TMHC cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -12830000.00
TMHC balance_sheet (annual, 2025-12-31) — Net PPE: 680505000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Net PPE: 680505000.00
TMHC cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -40372000.00
TMHC cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -11132000.00
TMHC cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
TMHC balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 5630125000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 5630125000.00
TMHC balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 74363000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 74363000.00
TMHC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 74363000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 74363000.00
TMHC income_statement (annual, 2025-12-31) — Normalized EBITDA: 1188723000.00
TMHC income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 278813000.00
TMHC income_statement (annual, 2025-12-31) — Normalized Income: 792612916.00
TMHC income_statement (quarterly, 2025-12-31) — Normalized Income: 174016000.00
TMHC cash_flow (annual, 2025-12-31) — Operating Cash Flow: 817345000.00
TMHC cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 646431000.00
TMHC cash_flow (annual, 2025-12-31) — Operating Gains Losses: 8457000.00
TMHC cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 12011000.00
TMHC income_statement (annual, 2025-12-31) — Operating Income: 1135217000.00
TMHC income_statement (quarterly, 2025-12-31) — Operating Income: 268203000.00
TMHC income_statement (annual, 2025-12-31) — Operating Revenue: 8121480000.00
TMHC income_statement (quarterly, 2025-12-31) — Operating Revenue: 2099640000.00
TMHC balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 96536827.00
TMHC balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 96536827.00
TMHC balance_sheet (annual, 2025-12-31) — Other Current Assets: 498946000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 498946000.00
TMHC balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 2597000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 2597000.00
TMHC income_statement (annual, 2025-12-31) — Other Gand A: 273506000.00
TMHC income_statement (quarterly, 2025-12-31) — Other Gand A: 74028000.00
TMHC income_statement (annual, 2025-12-31) — Other Income Expense: -46171000.00
TMHC income_statement (quarterly, 2025-12-31) — Other Income Expense: -28476000.00
TMHC cash_flow (annual, 2025-12-31) — Other Non Cash Items: 87620000.00
TMHC cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 49732000.00
TMHC balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 98560000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 98560000.00
TMHC income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -37714000.00
TMHC income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -16465000.00
TMHC balance_sheet (annual, 2025-12-31) — Other Properties: 319815000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Other Properties: 319815000.00
TMHC balance_sheet (annual, 2025-12-31) — Other Receivables: 241678000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Other Receivables: 241678000.00
TMHC income_statement (annual, 2025-12-31) — Other Special Charges: 13324000.00
TMHC balance_sheet (annual, 2025-12-31) — Payables: 290534000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Payables: 290534000.00
TMHC balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 588768000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 588768000.00
TMHC balance_sheet (annual, 2025-12-31) — Prepaid Assets: 67724000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 67724000.00
TMHC income_statement (annual, 2025-12-31) — Pretax Income: 1042043000.00
TMHC income_statement (quarterly, 2025-12-31) — Pretax Income: 227816000.00
TMHC cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: -493000.00
TMHC cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 443000.00
TMHC cash_flow (annual, 2025-12-31) — Purchase Of Business: -85578000.00
TMHC cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -12132000.00
TMHC cash_flow (annual, 2025-12-31) — Purchase Of Investment: -60608000.00
TMHC cash_flow (annual, 2025-12-31) — Purchase Of PPE: -40372000.00
TMHC cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -11132000.00
TMHC balance_sheet (annual, 2025-12-31) — Receivables: 241678000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Receivables: 241678000.00
TMHC income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 6251272000.00
TMHC income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1636815000.00
TMHC income_statement (annual, 2025-12-31) — Reconciled Depreciation: 40182000.00
TMHC income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 10610000.00
TMHC cash_flow (annual, 2025-12-31) — Repayment Of Debt: -4328435000.00
TMHC cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1456577000.00
TMHC cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -381016000.00
TMHC cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -71370000.00
TMHC balance_sheet (annual, 2025-12-31) — Restricted Cash: 1194000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 1194000.00
TMHC balance_sheet (annual, 2025-12-31) — Retained Earnings: 5176353000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 5176353000.00
TMHC cash_flow (annual, 2025-12-31) — Sale Of Investment: 1385000.00
TMHC income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 461485000.00
TMHC income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 120594000.00
TMHC income_statement (annual, 2025-12-31) — Selling General And Administration: 734991000.00
TMHC income_statement (quarterly, 2025-12-31) — Selling General And Administration: 194622000.00
TMHC balance_sheet (annual, 2025-12-31) — Share Issued: 162809286.00
TMHC balance_sheet (quarterly, 2025-12-31) — Share Issued: 162809286.00
TMHC cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 240000000.00
TMHC cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -240000000.00
TMHC income_statement (annual, 2025-12-31) — Special Income Charges: -13324000.00
TMHC cash_flow (annual, 2025-12-31) — Stock Based Compensation: 29049000.00
TMHC cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6712000.00
TMHC balance_sheet (annual, 2025-12-31) — Stockholders Equity: 6293322000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 6293322000.00
TMHC balance_sheet (annual, 2025-12-31) — Tangible Book Value: 5630125000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 5630125000.00
TMHC income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3211084.00
TMHC income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TMHC income_statement (annual, 2025-12-31) — Tax Provision: 250780000.00
TMHC income_statement (quarterly, 2025-12-31) — Tax Provision: 50720000.00
TMHC income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
TMHC income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.22
TMHC balance_sheet (annual, 2025-12-31) — Total Assets: 9837797000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Total Assets: 9837797000.00
TMHC balance_sheet (annual, 2025-12-31) — Total Capitalization: 8584429000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 8584429000.00
TMHC balance_sheet (annual, 2025-12-31) — Total Debt: 2362632000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Total Debt: 2362632000.00
TMHC balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 6309289000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 6309289000.00
TMHC income_statement (annual, 2025-12-31) — Total Expenses: 6986263000.00
TMHC income_statement (quarterly, 2025-12-31) — Total Expenses: 1831437000.00
TMHC balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3528508000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3528508000.00
TMHC balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1905043000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1905043000.00
TMHC balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2814711000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2814711000.00
TMHC income_statement (annual, 2025-12-31) — Total Other Finance Cost: 47003000.00
TMHC income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 11911000.00
TMHC balance_sheet (annual, 2025-12-31) — Total Tax Payable: 38893000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 38893000.00
TMHC income_statement (annual, 2025-12-31) — Total Unusual Items: -13324000.00
TMHC income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -13324000.00
TMHC balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 66272459.00
TMHC balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 66272459.00
TMHC balance_sheet (annual, 2025-12-31) — Treasury Stock: 2000527000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 2000527000.00
TMHC balance_sheet (annual, 2025-12-31) — Working Capital: 7218957000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Working Capital: 7218957000.00
TMHC income_statement (quarterly, 2026-03-31) — +Operating Expense: 148847000.00
TMHC income_statement (quarterly, 2026-03-31) — +Total Revenue: 1387092000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 255352000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 3113888000.00
TMHC cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 8182000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 139001000.00
TMHC income_statement (quarterly, 2026-03-31) — Basic Average Shares: 96033000.00
TMHC income_statement (quarterly, 2026-03-31) — Basic EPS: 1.03
TMHC cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 851231000.00
TMHC cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -9963000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 72822000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 652933000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 652933000.00
TMHC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -169234000.00
TMHC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -18133000.00
TMHC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -10431000.00
TMHC cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -40102000.00
TMHC cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 187000.00
TMHC cash_flow (quarterly, 2026-03-31) — Change In Inventory: -127337000.00
TMHC cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 29498000.00
TMHC cash_flow (quarterly, 2026-03-31) — Change In Payable: -39915000.00
TMHC cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -39915000.00
TMHC cash_flow (quarterly, 2026-03-31) — Change In Receivables: -6083000.00
TMHC cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 187000.00
TMHC cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -143837000.00
TMHC cash_flow (quarterly, 2026-03-31) — Changes In Cash: -197798000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6239780000.00
TMHC cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -149578000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 388277000.00
TMHC income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1096454000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 278882000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Current Assets: 7831305000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 154527000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 154527000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 732105000.00
TMHC cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 10735000.00
TMHC cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 10735000.00
TMHC income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 97530000.00
TMHC income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.01
TMHC income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 98625000.00
TMHC cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 4577000.00
TMHC cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 8750000.00
TMHC income_statement (quarterly, 2026-03-31) — EBIT: 141837000.00
TMHC income_statement (quarterly, 2026-03-31) — EBITDA: 152572000.00
TMHC income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 2877000.00
TMHC cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -2877000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 66806000.00
TMHC cash_flow (quarterly, 2026-03-31) — End Cash Position: 653433000.00
TMHC cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -169234000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Finished Goods: 6238563000.00
TMHC cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -20394000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 2245000.00
TMHC income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 58971000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Goodwill: 663197000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 663197000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Gross PPE: 720123000.00
TMHC income_statement (quarterly, 2026-03-31) — Gross Profit: 290638000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 8333000.00
TMHC income_statement (quarterly, 2026-03-31) — Interest Expense: 11155000.00
TMHC income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 11155000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Interest Payable: 35451000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Inventory: 6238563000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8581561000.00
TMHC cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -18133000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 483011000.00
TMHC cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 531191000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 0.00
TMHC balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 72822000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2341781000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2414603000.00
TMHC cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 531191000.00
TMHC cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -533880000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 483011000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 205439000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Minority Interest: 8374000.00
TMHC income_statement (quarterly, 2026-03-31) — Minority Interests: -1804000.00
TMHC cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -6483000.00
TMHC cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -149578000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Net Debt: 1688848000.00
TMHC income_statement (quarterly, 2026-03-31) — Net Income: 98625000.00
TMHC income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 98625000.00
TMHC income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 100429000.00
TMHC income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 98625000.00
TMHC income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 98625000.00
TMHC cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 100429000.00
TMHC income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 100429000.00
TMHC income_statement (quarterly, 2026-03-31) — Net Interest Income: -11155000.00
TMHC cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -10437000.00
TMHC cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -2689000.00
TMHC cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -2689000.00
TMHC income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -11155000.00
TMHC cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -9397000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Net PPE: 720123000.00
TMHC cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -9963000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5576583000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 74363000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 74363000.00
TMHC income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 152572000.00
TMHC income_statement (quarterly, 2026-03-31) — Normalized Income: 98625000.00
TMHC cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -10431000.00
TMHC cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -2877000.00
TMHC income_statement (quarterly, 2026-03-31) — Operating Income: 141791000.00
TMHC income_statement (quarterly, 2026-03-31) — Operating Revenue: 1387092000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 94488883.00
TMHC balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 530473000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 2245000.00
TMHC income_statement (quarterly, 2026-03-31) — Other Gand A: 58971000.00
TMHC income_statement (quarterly, 2026-03-31) — Other Income Expense: 46000.00
TMHC cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 5800000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 104892000.00
TMHC income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -2831000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Other Properties: 331846000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Other Receivables: 269835000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Payables: 298696000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 577578000.00
TMHC income_statement (quarterly, 2026-03-31) — Pretax Income: 130682000.00
TMHC cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: -7570000.00
TMHC cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -6483000.00
TMHC cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -16722000.00
TMHC cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -9963000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Receivables: 269835000.00
TMHC income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1096454000.00
TMHC income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 10735000.00
TMHC cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -533880000.00
TMHC cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -149578000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 500000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 5274978000.00
TMHC cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 6285000.00
TMHC income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 89876000.00
TMHC income_statement (quarterly, 2026-03-31) — Selling General And Administration: 148847000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Share Issued: 163218415.00
TMHC cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 6560000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 6239780000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5576583000.00
TMHC income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
TMHC income_statement (quarterly, 2026-03-31) — Tax Provision: 30253000.00
TMHC income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
TMHC balance_sheet (quarterly, 2026-03-31) — Total Assets: 9771999000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8581561000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Total Debt: 2414603000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 6248154000.00
TMHC income_statement (quarterly, 2026-03-31) — Total Expenses: 1245301000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3523845000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1940694000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2791740000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 43344000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 68729532.00
TMHC balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 2151332000.00
TMHC balance_sheet (quarterly, 2026-03-31) — Working Capital: 7099200000.00
TMI.L income_statement (annual, 2022-03-31) — +Operating Expense: 6205919.00
TMI.L income_statement (annual, 2022-03-31) — +Total Revenue: 259087454.00
TMI.L income_statement (annual, 2022-03-31) — Basic Average Shares: 314422685.00
TMI.L income_statement (annual, 2022-03-31) — Basic EPS: 0.80
TMI.L cash_flow (annual, 2022-03-31) — Beginning Cash Position: 0.00
TMI.L balance_sheet (annual, 2022-03-31) — Capital Stock: 333479334.00
TMI.L balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 3382410.00
TMI.L balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Federal Funds Sold: 3382410.00
TMI.L balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 3382410.00
TMI.L cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -11528775.00
TMI.L cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 0.00
TMI.L cash_flow (annual, 2022-03-31) — Change In Payable: 2305384.00
TMI.L cash_flow (annual, 2022-03-31) — Change In Receivables: -56821.00
TMI.L cash_flow (annual, 2022-03-31) — Change In Working Capital: 2248563.00
TMI.L cash_flow (annual, 2022-03-31) — Changes In Cash: 3437889.00
TMI.L balance_sheet (annual, 2022-03-31) — Common Stock: 333479334.00
TMI.L cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -11528775.00
TMI.L balance_sheet (annual, 2022-03-31) — Common Stock Equity: 575248769.00
TMI.L cash_flow (annual, 2022-03-31) — Common Stock Issuance: 237320000.00
TMI.L income_statement (annual, 2022-03-31) — Diluted Average Shares: 318704634.00
TMI.L income_statement (annual, 2022-03-31) — Diluted EPS: 0.79
TMI.L income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 252811565.00
TMI.L cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: -55479.00
TMI.L cash_flow (annual, 2022-03-31) — End Cash Position: 3382410.00
TMI.L balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 574114922.00
TMI.L cash_flow (annual, 2022-03-31) — Financing Cash Flow: 219272075.00
TMI.L cash_flow (annual, 2022-03-31) — Free Cash Flow: -215834186.00
TMI.L cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -471436438.00
TMI.L income_statement (annual, 2022-03-31) — Gain On Sale Of Security: 245569999.00
TMI.L income_statement (annual, 2022-03-31) — General And Administrative Expense: 5529934.00
TMI.L balance_sheet (annual, 2022-03-31) — Invested Capital: 575248769.00
TMI.L cash_flow (annual, 2022-03-31) — Investing Cash Flow: 0.00
TMI.L balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 574114922.00
TMI.L balance_sheet (annual, 2022-03-31) — Investments And Advances: 574114922.00
TMI.L cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 237320000.00
TMI.L cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 237320000.00
TMI.L cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 55479.00
TMI.L income_statement (annual, 2022-03-31) — Net Income: 252811565.00
TMI.L income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 252811565.00
TMI.L income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 252811565.00
TMI.L income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 252811565.00
TMI.L income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 252811565.00
TMI.L cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 252811565.00
TMI.L income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 252811565.00
TMI.L cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 0.00
TMI.L balance_sheet (annual, 2022-03-31) — Net PPE: 0.00
TMI.L cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: 0.00
TMI.L balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 575248769.00
TMI.L income_statement (annual, 2022-03-31) — Normalized Income: 7309512.97
TMI.L cash_flow (annual, 2022-03-31) — Operating Cash Flow: -215834186.00
TMI.L income_statement (annual, 2022-03-31) — Operating Revenue: 259087454.00
TMI.L balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 330215878.00
TMI.L balance_sheet (annual, 2022-03-31) — Other Equity Interest: 486645.00
TMI.L cash_flow (annual, 2022-03-31) — Other Non Cash Items: 486645.00
TMI.L balance_sheet (annual, 2022-03-31) — Other Payable: 533891.00
TMI.L balance_sheet (annual, 2022-03-31) — Payables: 603781.00
TMI.L income_statement (annual, 2022-03-31) — Pretax Income: 252881535.00
TMI.L cash_flow (annual, 2022-03-31) — Purchase Of PPE: 0.00
TMI.L balance_sheet (annual, 2022-03-31) — Receivables: 56821.00
TMI.L balance_sheet (annual, 2022-03-31) — Retained Earnings: 241282790.00
TMI.L income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 189340.00
TMI.L income_statement (annual, 2022-03-31) — Selling General And Administration: 5719274.00
TMI.L balance_sheet (annual, 2022-03-31) — Share Issued: 330215878.00
TMI.L balance_sheet (annual, 2022-03-31) — Stockholders Equity: 575248769.00
TMI.L balance_sheet (annual, 2022-03-31) — Tangible Book Value: 575248769.00
TMI.L income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 67946.97
TMI.L income_statement (annual, 2022-03-31) — Tax Provision: 69970.00
TMI.L income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.00
TMI.L balance_sheet (annual, 2022-03-31) — Total Assets: 577554153.00
TMI.L balance_sheet (annual, 2022-03-31) — Total Capitalization: 575248769.00
TMI.L balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 575248769.00
TMI.L balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 2305384.00
TMI.L balance_sheet (annual, 2022-03-31) — Total Tax Payable: 69890.00
TMI.L income_statement (annual, 2022-03-31) — Total Unusual Items: 245569999.00
TMI.L income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 245569999.00
TMI.L income_statement (annual, 2023-03-31) — +Operating Expense: 9944463.00
TMI.L income_statement (annual, 2023-03-31) — +Total Revenue: 36105394.00
TMI.L income_statement (annual, 2023-03-31) — Basic Average Shares: 330215878.00
TMI.L income_statement (annual, 2023-03-31) — Basic EPS: 0.08
TMI.L cash_flow (annual, 2023-03-31) — Beginning Cash Position: 3382410.00
TMI.L cash_flow (annual, 2023-03-31) — Capital Expenditure: -753780.00
TMI.L balance_sheet (annual, 2023-03-31) — Capital Stock: 333479334.00
TMI.L balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 11199937.00
TMI.L balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 11199937.00
TMI.L balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 11199937.00
TMI.L cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -36235666.00
TMI.L balance_sheet (annual, 2023-03-31) — Cash Financial: 11199937.00
TMI.L cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 0.00
TMI.L cash_flow (annual, 2023-03-31) — Change In Payable: 629806.00
TMI.L cash_flow (annual, 2023-03-31) — Change In Receivables: -497403.00
TMI.L cash_flow (annual, 2023-03-31) — Change In Working Capital: 132403.00
TMI.L cash_flow (annual, 2023-03-31) — Changes In Cash: 7996269.00
TMI.L balance_sheet (annual, 2023-03-31) — Common Stock: 333479334.00
TMI.L cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -36235666.00
TMI.L balance_sheet (annual, 2023-03-31) — Common Stock Equity: 566114300.00
TMI.L cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
TMI.L cash_flow (annual, 2023-03-31) — Common Stock Payments: 0.00
TMI.L cash_flow (annual, 2023-03-31) — Depreciation: 196691.00
TMI.L cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 196691.00
TMI.L income_statement (annual, 2023-03-31) — Diluted Average Shares: 330215878.00
TMI.L income_statement (annual, 2023-03-31) — Diluted EPS: 0.08
TMI.L income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 26210533.00
TMI.L cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -178742.00
TMI.L cash_flow (annual, 2023-03-31) — End Cash Position: 11199937.00
TMI.L balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 556738240.00
TMI.L cash_flow (annual, 2023-03-31) — Financing Cash Flow: -36235666.00
TMI.L cash_flow (annual, 2023-03-31) — Free Cash Flow: 44231935.00
TMI.L cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 17376682.00
TMI.L income_statement (annual, 2023-03-31) — Gain On Sale Of Security: -6376717.00
TMI.L income_statement (annual, 2023-03-31) — General And Administrative Expense: 8466899.00
TMI.L balance_sheet (annual, 2023-03-31) — Invested Capital: 566114300.00
TMI.L cash_flow (annual, 2023-03-31) — Investing Cash Flow: -753780.00
TMI.L balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 556738240.00
TMI.L balance_sheet (annual, 2023-03-31) — Investments And Advances: 556738240.00
TMI.L cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
TMI.L cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
TMI.L cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 159326.00
TMI.L income_statement (annual, 2023-03-31) — Net Income: 26210533.00
TMI.L income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 26210533.00
TMI.L income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 26210533.00
TMI.L income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 26210533.00
TMI.L income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 26210533.00
TMI.L cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 26210533.00
TMI.L income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 26210533.00
TMI.L cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 0.00
TMI.L balance_sheet (annual, 2023-03-31) — Net PPE: 557089.00
TMI.L cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -753780.00
TMI.L balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 566114300.00
TMI.L income_statement (annual, 2023-03-31) — Normalized Income: 31375673.77
TMI.L cash_flow (annual, 2023-03-31) — Operating Cash Flow: 44985715.00
TMI.L income_statement (annual, 2023-03-31) — Operating Revenue: 36105394.00
TMI.L balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 330215878.00
TMI.L cash_flow (annual, 2023-03-31) — Other Non Cash Items: 910080.00
TMI.L balance_sheet (annual, 2023-03-31) — Other Payable: 2772616.00
TMI.L balance_sheet (annual, 2023-03-31) — Payables: 2935190.00
TMI.L income_statement (annual, 2023-03-31) — Pretax Income: 26160931.00
TMI.L cash_flow (annual, 2023-03-31) — Purchase Of PPE: -753780.00
TMI.L balance_sheet (annual, 2023-03-31) — Receivables: 554224.00
TMI.L income_statement (annual, 2023-03-31) — Reconciled Depreciation: 196691.00
TMI.L cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: 0.00
TMI.L balance_sheet (annual, 2023-03-31) — Retained Earnings: 231257657.00
TMI.L income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 567484.00
TMI.L income_statement (annual, 2023-03-31) — Selling General And Administration: 9034383.00
TMI.L balance_sheet (annual, 2023-03-31) — Share Issued: 330215878.00
TMI.L balance_sheet (annual, 2023-03-31) — Stockholders Equity: 566114300.00
TMI.L balance_sheet (annual, 2023-03-31) — Tangible Book Value: 566114300.00
TMI.L income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -1211576.23
TMI.L income_statement (annual, 2023-03-31) — Tax Provision: -49602.00
TMI.L income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.19
TMI.L balance_sheet (annual, 2023-03-31) — Total Assets: 569049490.00
TMI.L balance_sheet (annual, 2023-03-31) — Total Capitalization: 566114300.00
TMI.L balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 566114300.00
TMI.L balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 2935190.00
TMI.L balance_sheet (annual, 2023-03-31) — Total Tax Payable: 162574.00
TMI.L income_statement (annual, 2023-03-31) — Total Unusual Items: -6376717.00
TMI.L income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -6376717.00
TMI.L balance_sheet (annual, 2023-03-31) — Treasury Stock: 0.00
TMI.L income_statement (annual, 2024-03-31) — +Operating Expense: 10740000.00
TMI.L income_statement (annual, 2024-03-31) — +Total Revenue: -42536000.00
TMI.L income_statement (annual, 2024-03-31) — Basic Average Shares: 330005000.00
TMI.L income_statement (annual, 2024-03-31) — Basic EPS: -0.16
TMI.L cash_flow (annual, 2024-03-31) — Beginning Cash Position: 11200000.00
TMI.L cash_flow (annual, 2024-03-31) — Capital Expenditure: -158000.00
TMI.L balance_sheet (annual, 2024-03-31) — Capital Stock: 333479000.00
TMI.L balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 3844000.00
TMI.L balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 3844000.00
TMI.L balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 3844000.00
TMI.L cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -26373000.00
TMI.L balance_sheet (annual, 2024-03-31) — Cash Financial: 3844000.00
TMI.L cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 0.00
TMI.L cash_flow (annual, 2024-03-31) — Change In Payable: -161000.00
TMI.L cash_flow (annual, 2024-03-31) — Change In Receivables: -172000.00
TMI.L cash_flow (annual, 2024-03-31) — Change In Working Capital: -333000.00
TMI.L cash_flow (annual, 2024-03-31) — Changes In Cash: -7180000.00
TMI.L balance_sheet (annual, 2024-03-31) — Common Stock: 333479000.00
TMI.L cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -26373000.00
TMI.L balance_sheet (annual, 2024-03-31) — Common Stock Equity: 485006000.00
TMI.L cash_flow (annual, 2024-03-31) — Common Stock Payments: -2400000.00
TMI.L cash_flow (annual, 2024-03-31) — Depreciation: 320000.00
TMI.L cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 320000.00
TMI.L income_statement (annual, 2024-03-31) — Diluted Average Shares: 330005000.00
TMI.L income_statement (annual, 2024-03-31) — Diluted EPS: -0.16
TMI.L income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -53482000.00
TMI.L cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -176000.00
TMI.L cash_flow (annual, 2024-03-31) — End Cash Position: 3844000.00
TMI.L balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 483444000.00
TMI.L cash_flow (annual, 2024-03-31) — Financing Cash Flow: -28773000.00
TMI.L cash_flow (annual, 2024-03-31) — Free Cash Flow: 21593000.00
TMI.L cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: 73294000.00
TMI.L income_statement (annual, 2024-03-31) — Gain On Sale Of Security: -73594000.00
TMI.L income_statement (annual, 2024-03-31) — General And Administrative Expense: 8598000.00
TMI.L balance_sheet (annual, 2024-03-31) — Invested Capital: 485006000.00
TMI.L cash_flow (annual, 2024-03-31) — Investing Cash Flow: -158000.00
TMI.L balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 483444000.00
TMI.L balance_sheet (annual, 2024-03-31) — Investments And Advances: 483444000.00
TMI.L cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: -2400000.00
TMI.L cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 210000.00
TMI.L income_statement (annual, 2024-03-31) — Net Income: -53482000.00
TMI.L income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -53482000.00
TMI.L income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -53482000.00
TMI.L income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -53482000.00
TMI.L income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -53482000.00
TMI.L cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -53482000.00
TMI.L income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -53482000.00
TMI.L cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 0.00
TMI.L balance_sheet (annual, 2024-03-31) — Net PPE: 395000.00
TMI.L cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -158000.00
TMI.L balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 485006000.00
TMI.L income_statement (annual, 2024-03-31) — Normalized Income: 1713500.00
TMI.L cash_flow (annual, 2024-03-31) — Operating Cash Flow: 21751000.00
TMI.L income_statement (annual, 2024-03-31) — Operating Revenue: -42536000.00
TMI.L balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 327652420.00
TMI.L cash_flow (annual, 2024-03-31) — Other Non Cash Items: 1742000.00
TMI.L balance_sheet (annual, 2024-03-31) — Other Payable: 3323000.00
TMI.L balance_sheet (annual, 2024-03-31) — Payables: 3402000.00
TMI.L income_statement (annual, 2024-03-31) — Pretax Income: -53276000.00
TMI.L cash_flow (annual, 2024-03-31) — Purchase Of PPE: -158000.00
TMI.L balance_sheet (annual, 2024-03-31) — Receivables: 725000.00
TMI.L income_statement (annual, 2024-03-31) — Reconciled Depreciation: 320000.00
TMI.L cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: -2400000.00
TMI.L balance_sheet (annual, 2024-03-31) — Retained Earnings: 151402000.00
TMI.L income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 400000.00
TMI.L income_statement (annual, 2024-03-31) — Selling General And Administration: 8998000.00
TMI.L balance_sheet (annual, 2024-03-31) — Share Issued: 330215878.00
TMI.L balance_sheet (annual, 2024-03-31) — Stockholders Equity: 485006000.00
TMI.L balance_sheet (annual, 2024-03-31) — Tangible Book Value: 485006000.00
TMI.L income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -18398500.00
TMI.L income_statement (annual, 2024-03-31) — Tax Provision: 206000.00
TMI.L income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.25
TMI.L balance_sheet (annual, 2024-03-31) — Total Assets: 488408000.00
TMI.L balance_sheet (annual, 2024-03-31) — Total Capitalization: 485006000.00
TMI.L balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 485006000.00
TMI.L balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3402000.00
TMI.L balance_sheet (annual, 2024-03-31) — Total Tax Payable: 79000.00
TMI.L income_statement (annual, 2024-03-31) — Total Unusual Items: -73594000.00
TMI.L income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -73594000.00
TMI.L balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 2563458.00
TMI.L balance_sheet (annual, 2024-03-31) — Treasury Stock: 2400000.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Capital Stock: 333600340.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 3558907.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Federal Funds Sold: 3558907.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 3558907.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Cash Financial: 3558907.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Common Stock: 333600340.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 486438779.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 484493243.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Invested Capital: 486438779.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 484493243.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 484493243.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Net PPE: 271800.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 486438779.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 328963051.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Other Payable: 2518208.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Payables: 2611942.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Receivables: 726771.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Retained Earnings: 152071890.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Share Issued: 330215878.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 486438779.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 486438779.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Total Assets: 489050721.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 486438779.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 486438779.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 2611942.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 93734.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 1252827.00
TMI.L balance_sheet (quarterly, 2024-09-30) — Treasury Stock: 1172985.00
TMI.L income_statement (annual, 2025-03-31) — +Operating Expense: 11880000.00
TMI.L income_statement (annual, 2025-03-31) — +Total Revenue: 0.00
TMI.L balance_sheet (annual, 2025-03-31) — Accounts Payable: 0.00
TMI.L balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 0.00
TMI.L balance_sheet (annual, 2025-03-31) — Accounts Receivable: 0.00
TMI.L balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 0.00
TMI.L balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -802000.00
TMI.L balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -802000.00
TMI.L balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
TMI.L balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
TMI.L balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 0.00